Serum albumin disrupts Cryptococcus neoformans and Bacillus anthracis extracellular vesicles

Julie M Wolf1, Johanna Rivera, Arturo Casadevall

  • 1Department of Microbiology and Immunology, Albert Einstein College of Medicine, Bronx, NY 10461, USA.

Cellular Microbiology
|February 1, 2012
PubMed

Insights

Pathogenic microbial extracellular vesicles are unstable in vivo, rapidly destabilizing via albumin. This albumin-mediated destabilization suggests a novel mechanism for microbial factor release and potential therapeutic targeting.

Area of Science:

  • Microbiology
  • Pathogenesis
  • Extracellular Vesicles

Background:

  • Extracellular vesicles (EVs) from pathogenic fungi and bacteria contain virulence factors.
  • Vesicle synthesis, stability, and cargo unloading mechanisms remain unclear.
  • Understanding EV function is crucial for deciphering microbial pathogenesis.

Purpose of the Study:

  • To investigate the kinetics of vesicle production and stability in Cryptococcus neoformans.
  • To determine factors influencing EV stability and cargo release.
  • To elucidate the role of serum components in EV destabilization.

Main Methods:

  • Metabolic labeling with [1-(14)C] palmitic acid to track vesicle production.
  • Dynamic light scattering to assess vesicle size and stability.
  • Density gradient analysis to characterize vesicle cargo.
  • Incubation of vesicles with immune cells and serum components.

Main Results:

  • Cryptococcus neoformans EVs are produced throughout all growth phases and are stable upon isolation.
  • Vesicle cargo is heterogeneous, with only a portion containing cryptococcal polysaccharide.
  • EVs rapidly destabilize upon incubation with macrophages, mediated by serum albumin.
  • Albumin, mouse serum, and murine immunoglobulin destabilized Bacillus anthracis EVs, but not ovalbumin or keyhole limpet haemocyanin.

Conclusions:

  • Cryptococcal EVs are likely short-lived in vivo.
  • Albumin is a key mediator of EV destabilization and cargo offload.
  • Albumin exhibits a novel activity in promoting microbial EV release, suggesting therapeutic implications.